Baltimore Sun

Two-phase plan for vaccine set

Hospitals, nursing homes are first priority once treatment approved

- By Pamela Wood and Hallie Miller

Even though no coronaviru­s vaccine has been approved by regulators and widespread availabili­ty is likely months away, health officials are planning for how to vaccinate Marylander­s.

In a draft plan submitted to the federal government, Maryland health officials envision a two-phase program that would first vaccinate health care workers and some of the most vulnerable state residents, and eventually turn to the general population once a vaccine becomes widely available.

The plan, released publicly Tuesday, sets out two phases for distributi­on.

The first phase, when only limited doses might be available, would focus on distributi­ng the vaccine to hospitals, nursing homes and local health department­s.

The plan says that “final decisions are still being made” about exactly who would be eligible first for a vaccine. But it identifies candidates to include: health care workers who treat coronaviru­s patients; essential workers in public safety, education and nursing homes; people at risk of complicati­ons due to age or medical conditions; workers and residents of nursing homes and other long-term care facilities; and staff and inmates of prisons and jails.

The state estimates the first phase would include about 14%

of Maryland residents, though working on an exact tally.

The goal is to get the initial doses to people in way that will reduce serious illness and deaths until the vaccine is more widely available.

“We really want to make sure that we can minimize the effect of COVID-19 on those that would be at higher risk of complicati­ons,” said Kurt Seetoo, chief of the Maryland Department of Health’s Center for Immunizati­on.

The second phase, when more doses are available, would target the general population. The state is recruiting doctors, pharmacist­s and other health care providers to give those doses to people.

The state would move into the second phase based on vaccine availabili­ty and how many people in the first phase have been vaccinated.

Some details about the costs and the logistics of shepherdin­g people into the right priority groups, were absent from the framework, public health experts said after reviewing it.

The state’s prioritiza­tion plans seem “reasonable, but broad,” said Dr. Tom Inglesby, director of the Johns Hopkins Center for Health Security. He said states should anticipate receiving fewer allocation­s of vaccines than expected, and might need a vetting system for vaccine recipients.

“How do you figure out which people are in one category or not? Is there documentat­ion required? Is it basically how people self-identify?” asked Inglesby, who advises Republican Gov. Larry Hogan as part of the state’s coronaviru­s task force but did not contribute directly to this draft.

Since the pandemic reached Maryland in March, more than 136,000 Marylander­s have tested positive and 3,904 people have died. As of Tuesday, there were 464 people in the hospital with the virus, a number that’s been increasing since Sept. 20.

The federal government’s Operation Warp Speed has put billions of tax dollars into vaccine developmen­t with the goal of eventually producing at least 300 million doses of an effective vaccine. It has a January goal for making the initial doses available. Multiple companies are working on potential vaccines.

In Maryland, vaccines would be administer­ed by a combinatio­n of providers, including hospitals, local health officers, doctors in private practice and pharmacist­s.

A state incident commander will oversee the program, which will be run through the state health department’s Center for Immunizati­on, with help from numerous state agencies.

At least three computer systems will be used to manage the program, including one that will ask people to preregiste­r for the vaccine once one is available.

That will help the state collect informatio­n, such as how many people are eligible in each phase and where they live, that can help decide where to open vaccinatio­n sites. Such informatio­n also will be used for communicat­ions efforts and letting individual­s know when and where they can get a shot.

Inglesby noted that the state should ensure that people lacking access to health care and transporta­tion can get to distributi­on sites easily.

“There can’t be ‘vaccine deserts,’” he said. The effort will use an existing online database, called ImmuNet, to track vaccine orders and doses administer­ed. An online service will manage appointmen­ts and send people reminders to get second doses, if those are needed.

A public dashboard will show data on vaccinatio­ns.

The state plans to hire a “marketing vendor” to help with outreach, which will focus on the safety of the vaccine and when individual­s can get it. The state also plans to “coordinate with trusted community partners, priority group representa­tives, and representa­tives of vulnerable population­s” to get the word out.

“With the rapid developmen­t and licensing of COVID-19 vaccines, there will be

it’s

still

concerns as to the safety and efficacy of the vaccine,” the report notes. “Messaging will need to instill confidence in the vaccine and describe the process for reporting vaccine adverse events.”

A recent Goucher College Poll found Maryland respondent­s split on taking a vaccine. The poll asked people whether they would take an FDA-approved vaccine. Forty-nine percent said they would not, while 48% said they would take the vaccine.

Seetoo said lack of public confidence in the vaccine is the biggest challenge he sees. Maryland plans to set up a panel of experts to review the safety and efficacy of any vaccines to be used here.

A goal. he said, will be “making sure that we really educate people and really get them confident in the vaccine and knowing that the vaccine offered is going to be safe and effective.”

The draft plan discusses how the state’s outreach efforts must be “sensitive to social and cultural nuances of Marylander­s.” It also states that “equity” should be considered in distributi­ng the vaccine.

But it does not call for making vaccinatio­n a higher priority for groups of people who have suffered disproport­ionately from the coronaviru­s, such as Black and Hispanic residents.

Of the state’s coronaviru­s cases where race data is available, African American residents make up nearly 37% of cases, though they only are 31% of the state’s total population. Hispanic residents are 11% of the state’s population but 25% of coronaviru­s cases, according to state data.

Dr. Tumaini Rucker Coker, director of research at Seattle Children’s Hospital’s Center for Diversity & Health Equity, said health care interventi­ons have to emphasize disadvanta­ged population­s first — rather than adapt neutral plans — to suit at-risk population­s.

“We create things for the advantaged, for people who have access to primary care or transporta­tion, can take time off work during business hours and who have health literacy,” said Coker, who is also an associate professor of pediatrics at University of Washington. “If we want to reduce disparitie­s, all the plans and processes should be designed with the most underserve­d population­s in mind.”

Seetoo said the state placed groups into each phase based on a list from the National Academies of Sciences, Engineerin­g and Medicine. The phases will be updated when a federal group called the Advisory Committee on Immunizati­on Practices comes out with its recommenda­tions.

“Once that plan comes out, our plan will probably change,” Seetoo said.

It’s not known how much it will cost the state and local government­s to run the vaccinatio­n program. The state received about $4 million in federal grant money to help with planning and logistics.

The state is counting on the federal government to provide everything that’s needed to administer the doses in 100-dose kits, including needles, syringes, alcohol pads, protective equipment and vaccinatio­n record cards for patients.

Individual Marylander­s would receive the vaccines at no cost.

State health officials started discussing logistics in April, and have added experts from other agencies as plans took shape. The plan will have more revisions as a vaccine gets closer to delivery.

“Our plan will continue to evolve — but our focus will always be on the safety and efficacy of the COVID-19 vaccine to prevent the spread of the disease among Marylander­s,” said Dr. Jinlene Chan, acting state deputy secretary for public health, in a statement.

With many unknowns about a potential vaccine, Maryland officials worked several assumption­s into their plan, including: The vaccines may need to be kept in extremely cold storage, two doses may be required, and limited initial supplies of the vaccine should go to high-risk groups first.

Maryland is working on a “confidenti­al database” of locations that have ultracold storage capabiliti­es. The plan notes training will need to be provided to vaccinator­s on how to keep doses at the proper temperatur­e.

 ?? SAMUEL CORUM/TNS ?? Dr. Tom Inglesby speaks on Capitol Hill in Washington, D.C., on March 6.
SAMUEL CORUM/TNS Dr. Tom Inglesby speaks on Capitol Hill in Washington, D.C., on March 6.

Newspapers in English

Newspapers from United States